Vamorolone, a dissociative steroidal compound, reduces collagen antibody-induced joint damage and inflammation when administered after disease onset
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vamorolone, a dissociative steroidal compound, reduces collagen antibody-induced joint damage and inflammation when administered after disease onset
Authors
Keywords
Rheumatoid arthritis, Glucocorticoids, Inflammation, Autoimmunity
Journal
INFLAMMATION RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-24
DOI
10.1007/s00011-019-01279-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes
- (2018) Eric P. Hoffman et al. STEROIDS
- Cryptic glucocorticoid receptor-binding sites pervade genomic NF-κB response elements
- (2018) William H. Hudson et al. Nature Communications
- Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit
- (2018) Sen Chandra Sreetama et al. MOLECULAR THERAPY
- VBP15, a novel dissociative steroid compound, reduces NFκB-induced expression of inflammatory cytokines in vitro and symptoms of murine trinitrobenzene sulfonic acid-induced colitis
- (2016) Jesse M. Damsker et al. INFLAMMATION RESEARCH
- Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
- (2016) Theo Vos et al. LANCET
- Glucocorticoids in Early Rheumatoid Arthritis: Are the Benefits of Joint-Sparing Effects Offset by the Adverse Effect of Osteoporosis? The Effects on Bone in the Utrecht Study and the CAMERA-II Study
- (2015) Johannes W.G. Jacobs et al. NEUROIMMUNOMODULATION
- Glucocorticoids in the treatment of rheumatoid arthritis: still used after 65 years
- (2014) Johannes W.J. Bijlsma et al. Annals of the New York Academy of Sciences
- VBP15, a Novel Anti-Inflammatory, is Effective at Reducing the Severity of Murine Experimental Autoimmune Encephalomyelitis
- (2014) Blythe C. Dillingham et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Role of cathepsin B in regulating migration and invasion of fibroblast-like synoviocytes into inflamed tissue from patients with rheumatoid arthritis
- (2014) B. Tong et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- VBP15: Preclinical characterization of a novel anti-inflammatory delta 9,11 steroid
- (2013) Erica K.M. Reeves et al. BIOORGANIC & MEDICINAL CHEMISTRY
- What do we know about the safety of corticosteroids in rheumatoid arthritis?
- (2013) Olivier Ethgen et al. CURRENT MEDICAL RESEARCH AND OPINION
- VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects
- (2013) Christopher R. Heier et al. EMBO Molecular Medicine
- VBP15, a Glucocorticoid Analogue, Is Effective at Reducing Allergic Lung Inflammation in Mice
- (2013) Jesse M. Damsker et al. PLoS One
- Collagen antibody-induced arthritis evokes persistent pain with spinal glial involvement and transient prostaglandin dependency
- (2012) Duygu B. Bas et al. ARTHRITIS AND RHEUMATISM
- The multiple facets of glucocorticoid action in rheumatoid arthritis
- (2012) Ulrike Baschant et al. Nature Reviews Rheumatology
- Developing an effective treatment algorithm for rheumatoid arthritis
- (2012) E. C. Keystone et al. RHEUMATOLOGY
- Non-invasive Optical Imaging of Muscle Pathology in mdx Mice Using Cathepsin Caged Near-Infrared Imaging
- (2010) Andreas R. Baudy et al. MOLECULAR IMAGING AND BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now